ロード中...
All-trans retinoic acid shifts rosiglitazone-induced adipogenic differentiation to osteogenic differentiation in mouse embryonic fibroblasts
Rosiglitazone (RSG) is a potent drug used in the treatment of insulin resistance; however, it is associated with marked skeletal toxicity. RSG-induced osteoporosis may contribute to the promotion of adipogenic differentiation at the expense of osteogenic differentiation in bone marrow stromal cells....
保存先:
| 出版年: | Int J Mol Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5117762/ https://ncbi.nlm.nih.gov/pubmed/27779644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2016.2782 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|